Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DOPAMINE AGONISTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 362 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Williams, JC; Stone, D; Smith-Arica, JR; Morris, ID; Lowenstein, PR; Castro, MG
      Regulated, adenovirus-mediated delivery of tyrosine hydroxylase suppressesgrowth of estrogen-induced pituitary prolactinomas

      MOLECULAR THERAPY
    2. Carvey, PM; McGuire, SO; Ling, ZD
      Neuroprotective effects of D3 dopamine receptor agonists

      PARKINSONISM & RELATED DISORDERS
    3. Caraceni, T; Musicco, M
      Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study

      PARKINSONISM & RELATED DISORDERS
    4. Stiasny, K
      Handling the problem of augmentation in restless legs syndrome (RLS)

      EUROPEAN JOURNAL OF NEUROLOGY
    5. Oertel, WH; Stiasny, K
      Differential therapy of nocturnal motor complications: case reports

      EUROPEAN JOURNAL OF NEUROLOGY
    6. Okura, M; Fujiki, N; Ripley, B; Takahashi, S; Amitai, N; Mignot, E; Nishino, S
      Narcoleptic canines display periodic leg movements during sleep

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    7. Malcolm, R; Herron, J; Sutherland, SE; Brady, KT
      Adverse outcomes in a controlled trial of pergolide for cocaine dependence

      JOURNAL OF ADDICTIVE DISEASES
    8. Eckardt, KM; Trenkwalder, C
      The restless legs syndrome

      PHLEBOLOGIE
    9. Sikiric, P; Seiwerth, S; Grabarevic, Z; Balen, I; Aralica, G; Gjurasin, M; Komericki, L; Perovic, D; Ziger, T; Anic, T; Prkacin, I; Separovic, J; Stancic-Rokotov, D; Lovric-Bencic, M; Mikus, D; Staresinic, M; Aralica, J; DiBaggio, N; Simec, Z; Turkovic, B; Rotkvic, I; Mise, S; Rucman, R; Petek, M; Sebecic, B; Ivasovic, Z; Boban-Blagaic, A; Sjekavica, I
      Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and methylprednisolone

      JOURNAL OF PHYSIOLOGY-PARIS
    10. Sikiric, P; Seiwerth, S; Aralica, G; Perovic, D; Staresinic, M; Anic, T; Gjurasin, M; Prkacin, I; Separovic, J; Stancic-Rokotov, D; Lovric-Bencic, M; Mikus, D; Turkovic, B; Rotkvic, I; Mise, S; Rucman, R; Petek, M; Ziger, T; Sebecic, B; Ivasovic, Z; Jagic, V; Komericki, L; Balen, I; Boban-Blagaic, A; Sjekavica, I
      Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat

      JOURNAL OF PHYSIOLOGY-PARIS
    11. Prkacin, I; Aralica, G; Perovic, D; Separovic, J; Gjurasin, M; Lovric-Bencic, M; Stancic-Rokotov, D; Ziger, T; Anic, T; Sikiric, P; Seiwerth, S; Staresinic, M; Mise, S; Rotkvic, I; Jagic, V; Rucman, R; Petek, M; Turkovic, B; Marovic, A; Sjekavica, I; Sebecic, B; Boban-Blagaic, A; Ivasovic, Z
      Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronicalcohol drinking rats.

      JOURNAL OF PHYSIOLOGY-PARIS
    12. Prkacin, I; Separovic, J; Aralicia, G; Perovic, D; Gjurasin, M; Lovric-Bencic, M; Stancic-Rokotov, D; Staresinic, M; Anic, T; Mikus, D; Sikiric, P; Seiwerth, S; Mise, S; Rotkvic, I; Jagic, V; Rucman, R; Petek, M; Turkovic, B; Marovic, A; Sebecic, B; Boban-Blagaic, A; Kokic, N
      Portal hypertension and liver lesions in chronically alcohol drinking ratsprevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine

      JOURNAL OF PHYSIOLOGY-PARIS
    13. Meltzer, H; Lee, MA; Jayathilake, K
      The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    14. Molitch, ME
      Disorders of prolactin secretion

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    15. Bourin, M; Fiocco, AJ; Clenet, F
      How valuable are animal models in defining antidepressant activity?

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    16. Tracik, F; Ebersbach, G
      Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings

      MOVEMENT DISORDERS
    17. Stocchi, F; Vacca, L; Berardelli, A; De Pandis, F; Ruggieri, S
      Long-duration effect and the postsynaptic compartment: Study using a dopamine agonist with a short half-life

      MOVEMENT DISORDERS
    18. Tirelli, E
      Day-by-day maturation of the long-term expression of cocaine sensitizationacquired before weaning in the rat

      BEHAVIORAL NEUROSCIENCE
    19. Pollack, AE
      Anatomy, physiology and pharmacology of the basal ganglia

      NEUROLOGIC CLINICS
    20. Ahlskog, JE
      Parkinson's disease: Medical and surgical treatment

      NEUROLOGIC CLINICS
    21. Cappabianca, P; Lodrini, S; Felisati, G; Peca, C; Cozzi, R; Di Sarno, A; Cavallo, LM; Giombini, S; Colao, A
      Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    22. Rascol, O; Fabre, N
      Dyskinesia: L-dopa-induced and tardive dyskinesia

      CLINICAL NEUROPHARMACOLOGY
    23. Gimenez-Roldan, S; Esteban, EM; Mateo, D
      Switching from bromocriptine to ropinirole in patients with advanced Parkinson's disease: Open label pilot responses to three different dose-ratios

      CLINICAL NEUROPHARMACOLOGY
    24. Jankovic, J; Tan, EK
      Choosing dopamine agonists in Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    25. Lavin, A; Grace, AA
      Stimulation of D1-type dopamine receptors enhances excitability in prefrontal cortical pyramidal neurons in a state-dependent manner

      NEUROSCIENCE
    26. Hanna, PA; Ratkos, L; Ondo, WG; Jankovic, J
      Switching from pergolide to pramipexole in patients with Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    27. Tuite, P; Ebbitt, B
      Dopamine agonists

      SEMINARS IN NEUROLOGY
    28. Hou, XY; Tang, FM; Zhang, GY
      Stimulation of dopamine receptors inhibited Ca2+-calmodulin dependent protein kinase II activity in rat striatal slices

      ACTA PHARMACOLOGICA SINICA
    29. Nomikos, P; Buchfelder, M; Fahlbusch, R
      Current management of prolactinomas

      JOURNAL OF NEURO-ONCOLOGY
    30. Bannerman, DM; Gilmour, G; Norman, G; Lemaire, M; Iversen, SD; Rawlins, JNP
      The time course of the hyperactivity that follows lesions or temporary inactivation of the fimbria-fornix

      BEHAVIOURAL BRAIN RESEARCH
    31. Westerink, BHC; De Vries, JB
      A method to evaluate the diffusion rate of drugs from a microdialysis probe through brain tissue

      JOURNAL OF NEUROSCIENCE METHODS
    32. Buchner, IK; Metz, P
      A rapid and general access to 3-arylpiperidines

      TETRAHEDRON LETTERS
    33. Hagag, P; Hertzianu, I; Ben-Shlomo, A; Weiss, M
      Androgen suppression and clinical improvement with dopamine agonists in hyperandrogenic-hyperprolactinemic women

      JOURNAL OF REPRODUCTIVE MEDICINE
    34. Bilic, I; Zoricic, I; Anic, T; Separovic, J; Stancic-Rokotov, D; Mikus, D; Buljat, G; Ivankovic, D; Aralica, G; Prkacin, I; Perovic, D; Mise, S; Rotkvic, I; Petek, M; Rucman, R; Seiwerth, S; Sikiric, P
      Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice

      LIFE SCIENCES
    35. Xia, XG; Schmidt, N; Teismann, P; Ferger, B; Schulz, JB
      Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation

      JOURNAL OF NEUROCHEMISTRY
    36. Pombo, JLH
      Clinical management of hyperprolactinemia

      REVISTA CLINICA ESPANOLA
    37. Anderson, DW; Neavin, T; Smith, JA; Schneider, JS
      Neuroprotective effects of pramipexole in young and aged MPTP-treated mice

      BRAIN RESEARCH
    38. Mukand, JA; Guilmette, TJ; Allen, DG; Brown, LK; Brown, SL; Tober, KL; VanDyck, WR
      Dopaminergic therapy with carbidopa L-dopa for left neglect after stroke: A case series

      ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
    39. Touraine, F; Plu-Bureau, G; Beji, C; Mauvais-Jarvis, F; Kuttenn, F
      Long-term follow-up of 246 hyperprolactinemic patients

      ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    40. Asano, S; Ueki, K; Suzuki, I; Kirino, T
      Clinical features and medical treatment of male prolactinomas

      ACTA NEUROCHIRURGICA
    41. Swerdlow, NR; Platten, A; Shoemaker, J; Pitcher, L; Auerbach, P
      Effects of pergolide on sensorimotor gating of the startle reflex in rats

      PSYCHOPHARMACOLOGY
    42. Platt, DM; Rowlett, JK; Spealman, RD
      Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys

      PSYCHOPHARMACOLOGY
    43. Venkataraman, R; Kellum, JA
      Novel approaches to the treatment of acute renal failure

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    44. Stiasny, K; Wetter, TC; Trenkwalder, C; Oertel, WH
      Restless legs syndrome and its treatment by dopamine agonists

      PARKINSONISM & RELATED DISORDERS
    45. Stern, MB
      The early treatment of Parkinson's disease: levodopa, dopamine agonists orboth

      PARKINSONISM & RELATED DISORDERS
    46. Lledo, A
      Dopamine agonists: the treatment for Parkinson's disease in the XXI century?

      PARKINSONISM & RELATED DISORDERS
    47. Rinne, UK
      Treatment of early Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    48. Ferreira, JJ; Rascol, O
      Drug-related sleep disturbances and Parkinson's disease: effects of dopaminergic antiparkinsonian drugs on sleep and wakefulness

      EUROPEAN JOURNAL OF NEUROLOGY
    49. Olanow, CW
      The management of unintended sleep episodes in patients with Parkinson's disease

      EUROPEAN JOURNAL OF NEUROLOGY
    50. de Yebenes, JG
      Introduction: pramipexole: a novel dopamine agonist for the treatment of Parkinson's disease

      EUROPEAN JOURNAL OF NEUROLOGY
    51. Olanow, CW; Stocchi, F
      Why delaying levodopa is a good treatment strategy in early Parkinson's disease

      EUROPEAN JOURNAL OF NEUROLOGY
    52. Shulman, LM
      How to succeed in using dopamine agonists in Parkinson's disease

      EUROPEAN JOURNAL OF NEUROLOGY
    53. Hubble, JP
      Pre-clinical studies of pramipexole: clinical relevance

      EUROPEAN JOURNAL OF NEUROLOGY
    54. Seedat, S; Kesler, S; Niehaus, DJH; Stein, DJ
      Pathological gambling behaviour: Emergence secondary to treatment of Parkinson's disease with dopaminergic agents

      DEPRESSION AND ANXIETY
    55. Ahlskog, JE
      Treatment of motor complications in advancing Parkinson's disease: Which drugs and when?

      FORMULARY
    56. Drange, MR; Nagelberg, SB; Braunstein, GD
      Uncoupled prolactin suppression and tumor shrinkage in bromocriptine-treated prolactinomas

      ENDOCRINOLOGIST
    57. Stefaneanu, L; Kovacs, K; Scheithauer, BW; Kontogeorgos, G; Riehle, DL; Sebo, TJ; Murray, D; Vidal, S; Tran, A; Buchfelder, M; Fahlbusch, R
      Effect of dopamine agonists on lactotroph adenomas of the human pituitary

      ENDOCRINE PATHOLOGY
    58. Melkersson, K; Hulting, AL
      Prolactin-secreting pituitary adenoma in neuroleptic treated patients withpsychotic disorder

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    59. Treseder, SA; Smith, LA; Jenner, P
      Endogenous dopaminergic tone and dopamine agonist action

      MOVEMENT DISORDERS
    60. Gerlach, M; Riederer, P; Reichmann, H
      Preclinical and clinical aspects of dopamine agonists. What is known for certain?

      NERVENHEILKUNDE
    61. Rees, DA; Davies, JS; Scanlon, MF
      Microprolactinoma: Medical or surgical treatment as first line approach? The case for medical therapy

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    62. Malcolm, R; Kajdasz, DK; Herron, J; Anton, RF; Brady, KT
      A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence

      DRUG AND ALCOHOL DEPENDENCE
    63. Jankovic, J
      Parkinson's disease therapy: Tailoring choices for early and late disease,young and old patients

      CLINICAL NEUROPHARMACOLOGY
    64. Drobny, M; Kurca, E
      Possible extrapyramidal system degradation in Parkinson's disease

      BRAIN RESEARCH BULLETIN
    65. Riederer, P; Sian, J; Gerlach, M
      Is there neuroprotection in Parkinson syndrome?

      JOURNAL OF NEUROLOGY
    66. Clarenbach, P
      Parkinson's disease and sleep

      JOURNAL OF NEUROLOGY
    67. Jost, WH; Berg-Mantkowski, A; Baas, H; Gemende, I; Glass, J; Kogan, E; Schneider, E; Storch, A
      Workshop III: Late motor complications of Parkinson's disease

      JOURNAL OF NEUROLOGY
    68. Kaye, CM; Nicholls, B
      Clinical pharmacokinetics of ropinirole

      CLINICAL PHARMACOKINETICS
    69. Melis, MR; Spano, MS; Succu, S; Argiolas, A
      Activation of gamma-aminobutyric acid(A) receptors in the paraventricular nucleus of the hypothalamus reduces apomorphine-, N-methyl-d-aspartic acid-and oxytocin-induced penile erection and yawning in male rats

      NEUROSCIENCE LETTERS
    70. Lal, S; Tesfaye, Y; Thavundayil, JX; Skorzewska, A; Schwartz, G
      Effect of time-of-day on the yawning response to apomorphine in normal subjects

      NEUROPSYCHOBIOLOGY
    71. Koch, M; Fendt, M; Kretschmer, BD
      Role of the substantia nigra pars reticulata in sensorimotor gating, measured by prepulse inhibition of startle in rats

      BEHAVIOURAL BRAIN RESEARCH
    72. Stiasny, K; Robbecke, J; Schuler, P; Oertel, WH
      Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline - An open clinical trial

      SLEEP
    73. Patel, YC; Ezzat, S; Chik, CL; Rorstad, OP; Serri, O; Ur, E; Wilkins, GE
      Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective

      CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE
    74. Casas, M; Prat, G; Robledo, P; Barbanoj, M; Kulisevsky, J; Jane, F
      Methylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    75. Munchau, A; Bhatia, KP
      Pharmacological treatment of Parkinson's disease

      POSTGRADUATE MEDICAL JOURNAL
    76. Corbin, AE; Meltzer, LT; Ninteman, FW; Wiley, JN; Cristoffersen, CL; Wustrow, DJ; Wise, LD; Pugsley, TA; Heffner, TG
      PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. II. Preclinical behavioral effects

      NEUROPHARMACOLOGY
    77. Obeso, JA; Rodriguez-Oroz, MC; Rodriguez, M; Macias, R; Alvarez, L; Guridi, J; Vitek, J; DeLong, MR
      Pathophysiologic basis of surgery for Parkinson's disease

      NEUROLOGY
    78. Gilbert, DL; Sethuraman, G; Sine, L; Peters, S; Salle, FR
      Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial

      NEUROLOGY
    79. Riechmann, H; Lachenmayer, L
      The first double-blinded long-term study of the effectivity and dyskinesiaprophylaxis of ropinirole

      NERVENARZT
    80. Landolt, AM; Lomax, N
      Gamma knife radiosurgery for prolactinomas

      JOURNAL OF NEUROSURGERY
    81. Windeatt, S; Southgate, TD; Dewey, RA; Bolognani, F; Perone, MJ; Larregina, AT; Maleniak, TC; Morris, ID; Goya, RG; Klatzmann, D; Lowenstein, PR; Castro, MG
      Adenovirus-mediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    82. Freda, PU; Andreadis, CI; Khandji, AG; Khoury, M; Bruce, JN; Jacobs, TP; Wardlaw, SL
      Long-term treatment of prolactin-secreting macroadenomas with pergolide

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    83. Drange, MR; Fram, NR; Herman-Bonert, V; Melmed, S
      Pituitary tumor registry: A novel clinical resource

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    84. Lahlou, S
      Blunted presser responsiveness to intravenous quinpirole in conscious, chronic spinal cord-transected rats: peripheral vs. spinal mechanisms

      EUROPEAN JOURNAL OF PHARMACOLOGY
    85. Rodenhuis, N; Timmerman, W; Wikstrom, HV; Dijkstra, D
      Thiophene analogs of naphthoxazines and 2-aminotetralins: bioisosteres with improved relative oral bioavailability, as compared to 5-OH-DPAT

      EUROPEAN JOURNAL OF PHARMACOLOGY
    86. Orrego, JJ; Barkan, AL
      Pituitary disorders - Drug treatment options

      DRUGS
    87. Treseder, SA; Jackson, M; Jenner, P
      The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primates

      BRITISH JOURNAL OF PHARMACOLOGY
    88. Prat, G; Robledo, P; Rubio, A; Barbanoj, M; Jane, F; Casas, M
      Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervatedrats

      BRAIN RESEARCH
    89. Retzow, A; Althaus, M; de Mey, C; Mazur, D; Vens-Cappell, B
      Study on the interaction of the dopamine agonist alpha-dihydroergocryptinewith the pharmacokinetics of digoxin

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    90. Bergamasco, B; Frattola, L; Muratorio, A; Piccoli, F; Mailland, F; Parnetti, L
      Alpha-dihydroergocryptine in the treatment of de novo parkinsonian patients: results of a multicentre, randomized, double-blind, placebo-controlled study

      ACTA NEUROLOGICA SCANDINAVICA
    91. Oechsner, M; Groenke, L; Mueller, D
      Pleural fibrosis associated with dihydroergocryptine treatment

      ACTA NEUROLOGICA SCANDINAVICA
    92. Zavala, AR; Nazarian, A; Crawford, CA; McDougall, SA
      Cocaine-induced behavioral sensitization in the young rat

      PSYCHOPHARMACOLOGY
    93. Colosimo, C; De Michele, M
      Motor fluctuations in Parkinson's disease: pathophysiology and treatment

      EUROPEAN JOURNAL OF NEUROLOGY
    94. Bevan, JS
      Management of pituitary tumours

      BRITISH MEDICAL JOURNAL
    95. Reddy, NL; Francesconi, I; Bellott, EM
      A short and efficient asymmetric synthesis of (1S,2R)-(+)-5-methoxy-1-methyl-2-(di-n-propylamino)tetralin hydrochloride (UH-232)

      TETRAHEDRON-ASYMMETRY
    96. Sikiric, P; Jadrijevic, S; Seiwerth, S; Sosa, T; Deskovic, S; Perovic, D; Aralica, G; Grabarevic, Z; Rucman, R; Petek, M; Jagic, V; Turkovic, B; Ziger, T; Rotkvic, I; Mise, S; Zoricic, I; Sebecic, B; Patrlj, L; Kocman, B; Sarlija, M; Mikus, D; Separovic, J; Hanzevacki, M; Gjurasin, M; Miklic, P; Buljat, G
      Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats

      JOURNAL OF PHYSIOLOGY-PARIS
    97. Kohno, H; Katayama, S; Ohuchi, Y; Ohkubo, Y
      Possible neural mechanisms involved in footshock stress-induced enhancement of exploratory behavior in mice

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    98. Newman, CB
      Medical therapy for acromegaly

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    99. Laprade, N; Soghomonian, JJ
      Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylaseis differentially altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates

      SYNAPSE
    100. Goulet, M; Morissette, M; Grondin, R; Falardeau, P; Bedard, PJ; Rostene, W; Di Paolo, T
      Neurotensin receptors and dopamine transporters: Effects of MPTP lesioningand chronic dopaminergic treatments in monkeys

      SYNAPSE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 23:22:28